Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy

Published:2020-06-02 Issue:11 Volume:27 Page:4515-4522
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Montagna Giacomo,Mamtani Anita,Knezevic Andrea,Brogi Edi,Barrio Andrea V.,Morrow Monica

Funder

NIH/NCI Cancer Center Support Grant

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-020-08650-z.pdf

Reference39 articles.

1. King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12(6):335–43.

2. Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC. Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes. Ann Surg Oncol. 2018;25(8):2241–48.

3. Mamtani A, Barrio AV, King TA, et al. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study. Ann Surg Oncol. 2016;23(11):3467–74.

4. Morrow M. Parsing pathologic complete response in patients receiving neoadjuvant chemotherapy for breast cancer. JAMA Oncol. 2016;2(4):516–7.

5. Vila J, Mittendorf EA, Farante G, et al. Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer. Ann Surg Oncol. 2016;23(11):3501–09.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axillary Management Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer;Clinical Breast Cancer;2024-08

2. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy;JAMA Oncology;2024-06-01

3. Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy;American Society of Clinical Oncology Educational Book;2024-06

4. Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network;La radiologia medica;2024-04-29

5. Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1–3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study;Breast Cancer Research;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3